Ethical Compliance
LINCOLN PHARMA
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
4.8%
Debt
0.2%
Liquidity
2%
Revenue
Debt
Liquidity
4.8%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Pharmaceutical Products | ₹566.00 |
| Other Income | ₹4.61 |
| Sale of Services | ₹5.22 |
| Other Operating Revenue | ₹9.33 |
Questionable
INR Crores
| Investment Gain | ₹22.79 |
Non Compliant
INR Crores
| Interest Income | ₹7.02 |
INR Crores
| Revenue from Questionable Sources: | ₹22.79 |
| Revenue from Non Compliant Sources: | ₹7.02 |
| Total: | ₹29.81 |
| Total Revenue: | ₹614.97 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹29.81
₹614.97
= 4.8%
questionable
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
